News
Report shows increase in blood cancer incidence and survival
A report on cancer in the US suggests the incidence of leukemia and myeloma has been on the rise in recent years, but the incidence of non-Hodgkin...
News
Assay intended to aid PV diagnosis cleared for use in US
The US Food and Drug Administration has granted 510(k) clearance for QIAGEN’s ipsogen® JAK2 RGQ PCR Kit (ipsogen JAK2 assay), and the company has...
News
Drug granted fast track designation for PNH
The US Food and Drug Administration (FDA) has granted fast track designation to Coversin™ for the treatment of paroxysmal nocturnal hemoglobinuria...
News
Immunotherapy exhibits antileukemic activity in high-risk patients
Blinatumomab has demonstrated activity in high-risk patients with Philadelphia chromosome-positive (Ph+) B-cell precursor acute lymphoblastic...
News
FDA lifts partial clinical hold for some selinexor trials
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on trials of selinexor (KPT-330) in patients with hematologic...
News
Phase 2 study of daratumumab in NHL won’t proceed
The phase 2 CARINA study of daratumumab in non-Hodgkin lymphoma (NHL) will not proceed to stage 2, according to Genmab A/S and Janssen Biotech,...
News
FDA grants priority review to sBLA for blinatumomab
The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for blinatumomab...
News
Warfarin, aspirin linked to higher risk of ICH in AFib
An analysis of data from the ARISTOTLE trial suggests patients with atrial fibrillation (AFib) have a higher risk of intracranial hemorrhage (ICH...
News
Studies support Zika screening in entire US blood supply
Results from a pair of studies suggest it is necessary to test for Zika virus in all blood donated in the US, even blood collected outside areas...
News
FDA grants priority review for BLA of CAR T-cell therapy
The US Food and Drug Administration (FDA) has granted priority review for a biologics license application (BLA) for CTL019 (tisagenlecleucel-T),...
News
Team identifies proteins that give malaria parasites ‘superpower’
Researchers say they have identified proteins that enable the malaria parasite Plasmodium falciparum to “walk through cell walls.” The team...
News
Donor screening assays more sensitive than diagnostic assays for Zika
New research suggests assays used to screen donated blood for the Zika virus are more sensitive than assays used to help physicians diagnose Zika...
News
Drug induces remission in patient with severe TA-TMA
MARSEILLE—An investigational drug has successfully treated a severe case of transplant-associated thrombotic microangiopathy (TA-TMA), according...
News
NCCN launches radiation therapy resource
The National Comprehensive Cancer Network® (NCCN®) recently launched the NCCN Radiation Therapy Compendium™, which provides a single access point...
News
Drug receives orphan designation for AML
The US Food and Drug Administration (FDA) has granted annamycin orphan designation for the treatment of acute myeloid leukemia (AML). Annamycin...